Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 20,318 |
|
|||||
| News | - | ||||||
| Day High | 61.395 | Low High |
|||||
| Day Low | 60.87 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Invesco Biotechnology and Genome ETF | PBE | AMEX | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| -0.5629 | -0.92% | 60.8724 | 16:15:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 61.21 | 60.87 | 61.395 | 60.8724 | 61.4353 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 121 | 20,318 | 61.10 | 1,241,391 | - | 52.47 - 67.76 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 100 | 60.8724 | USD |
Invesco Biotechnology and Genome ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 244.7M | 4.02M | - | 1.18M | 23.92M | 5.95 | 10.23 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Invesco Biotechnology an...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PBE Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 60.64 | 61.7771 | 59.4701 | 61.10 | 53,634 | 0.2324 | 0.38% |
| 1 Month | 63.67 | 63.81 | 59.3199 | 61.25 | 17,662 | -2.80 | -4.39% |
| 3 Months | 63.75 | 67.76 | 59.3199 | 63.94 | 15,667 | -2.88 | -4.51% |
| 6 Months | 52.70 | 67.76 | 52.57 | 63.08 | 12,931 | 8.17 | 15.51% |
| 1 Year | 62.65 | 67.76 | 52.47 | 61.79 | 10,359 | -1.78 | -2.84% |
| 3 Years | 75.42 | 79.92 | 51.3941 | 63.42 | 9,576 | -14.55 | -19.29% |
| 5 Years | 52.67 | 84.86 | 38.081 | 60.38 | 9,934 | 8.20 | 15.57% |
| The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified. |
